DohART-NET integrates preclinical (animal and stem cell models), bioinformatics and network science to identify and validate mechanisms that play key role in the pathogenesis of diseases.
Conditions during contraception and pregnancy (presence of chemical stressors, obesity, diabetes, nutritional status of the parents) have pivotal role on the future health of the developing embryo -cardiovascular, metabolomic and neurologic disorders.
Babies born after human ART technology represent a high (6 million) and well-characterized population for finding correlations between contraception -pregnancy – health status of the babies and adults for a better understanding of the future risk for diseases.
DohART-NET aims to promote efficient disease prevention and potential therapeutic intervention to overcome adverse diseases pathways.
This project has received funding from the European Union’s Horizon 2020-MSCA-ITN-2018 programme under grant agreement No. 812660